Vicarious Surgical Public Company (NYSE:RBOT)

Vicarious Surgical combines virtual reality with proprietary human-like surgical robotics to improve visibility and accuracy, and enable surgeons to perform minimally invasive surgery through a single micro-incision. The company's team of engineers hailing from MIT, Stanford, and Harvard University work together to break ground on new and relevant surgical robotics technology. Vicarious Surgical's technology was granted Breakthrough Device Designation by the U.S. FDA, making it the first, and only, surgical robot to receive this designation from the FDA.